Intelligence / Healthtech / New Clinical Trials / Eli Lilly and Company
Clinicaltrial registered5 Nov 2026
Eli Lilly and Company
5 Nov 2026: Trial registered · A Study of Imlunestrant (LY3484356) in Healthy Female Participants. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 5 Nov 2026
- Title
- A Study of Imlunestrant (LY3484356) in Healthy Female Participants
- Conditions
- Healthy
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- United States
- Country
- United States
- Reference
- NCT07918859
- Location
- United States
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Eli Lilly and Company
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Eli Lilly and Company in our registers.
18 NovEli Lilly and Companytrial registered · HealthtechClinical17 NovEli Lilly and Companytrial registered · HealthtechClinical13 NovEli Lilly and Companytrial registered · HealthtechClinical13 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical6 NovEli Lilly and Companytrial registered · HealthtechClinical4 NovEli Lilly and Companytrial registered · HealthtechClinical4 NovEli Lilly and Companytrial registered · HealthtechClinical28 OctEli Lilly and Companytrial registered · HealthtechClinical22 OctEli Lilly and Companytrial registered · HealthtechClinical
More from United States
New Clinical Trials
18 NovBrocShot Inctrial registered · A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected SkinClinical18 NovCoherus Oncology, Inc.trial registered · A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsClinical18 NovCugene Inc.trial registered · A Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid TumorsClinical18 NovDriscoll'strial registered · A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy AdultsClinical18 NovEpetometrial registered · A Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin Therapy for Weight Loss.Clinical18 NovEtta Vitatrial registered · A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood SugarClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.